corpuls Showcases an In-Ear Vital-Signs Monitor and a Mechanical CPR Device at AMTC 2026: Two European Air Medical Innovations Aiming for the U.S. Market

Published: October 30, 2026  |  Category: Industry

The two scarcest resources inside an air medical cabin are space and time. When a vital-signs monitor weighing just 8.6 grams — shaped like a wireless earbud — appears alongside a mechanical chest compression device that leaves most of the patient's chest accessible instead of surrounding it with a frame, the two products are answering exactly those two questions. Per Vertical Mag (published October 29, 2026; accessed and verified October 30, 2026; product specifications cross-verified against corpuls' official product pages): German medical technology company corpuls used the 2026 Air Medical Transport Conference (AMTC 2026, Fort Worth, Texas) to introduce American air medical professionals to two products it hopes to bring to the U.S. market — the corpuls auryx in-ear vital-signs monitor and the corpuls cpr mechanical chest compression device. Both are already certified and on the market internationally; both are awaiting U.S. Food and Drug Administration (FDA) authorization before they can be sold in the United States. This article unpacks the specifications and design logic of both devices, and what the lightweighting trend in monitoring and resuscitation equipment means for aviation medical coordination/dispatch services.

1. The Story: A German MedTech Company Active in 75+ Countries Introduces Two New Products in Fort Worth

AMTC — the Air Medical Transport Conference — is the air medical community's most important annual industry gathering in North America; the 2026 conference was held in Fort Worth, Texas. Per Vertical Mag, corpuls used the conference to introduce two products it hopes to bring to the U.S. market; both are already on sale outside the U.S. and are awaiting FDA authorization before they can be sold domestically. Founded in 1982 and based in Kaufering, Germany, corpuls develops patient monitors, defibrillators and resuscitation equipment for emergency services, hospitals and specialized rescue teams. "We are global in more than 75 countries, and our next move is coming to the U.S. with two products," said Dr. Eva Meyer, vice president of business development and commercial excellence at corpuls. Chris Karageorge, the company's U.S. director of sales and, per Meyer, its first U.S.-based employee, confirmed that the domestic regulatory process is still underway: "We're going through the process, but it is very well received outside the U.S. in 75 other countries." As of the report, no U.S. launch date or domestic pricing has been announced for either product.

2. The corpuls auryx: An 8.6-Gram In-Ear Monitor That Puts SpO2, Pulse and Temperature into a "Wireless Earbud"

Per Vertical Mag, cross-verified against corpuls' official product page (which describes it as a "medically approved in-ear sensor"): the corpuls auryx is an in-ear vital-signs monitor weighing just 8.6 grams. Resembling a wireless earbud, it is worn in the ear canal with a curved support resting around the outside of the ear, continuously measuring multiple vital signs — oxygen saturation (SpO2), pulse rate and body temperature — transmitted via Bluetooth to an app on a compatible smartphone or tablet. It can additionally track the pulse waveform and incorporates a three-axis accelerometer. According to the manufacturer's European information, the internal battery supports more than 10 hours of operation; the sensor is sold as a two-pack, accommodates three sizes of ear tips, and is stored in a dual-charging case. corpuls believes confined-space rescues, patient transport, and situations involving poor peripheral circulation are excellent potential applications. For air medical crews the appeal is obvious: one small wireless device combining multiple measurements, without the conventional fingertip sensor and a separate temperature probe. The auryx already holds European Class IIb medical-device certification and entered the international market in August 2026, but remains unauthorized for U.S. sale at this time.

3. The corpuls cpr: A Single-Arm Mechanical Compression Device That Hands "Consistent Compressions" to a Battery

corpuls' second product, the corpuls cpr, is a battery-powered, self-contained chest compression device intended to deliver consistent compressions during resuscitation. Unlike competitor systems that surround the patient's chest with a larger frame, the corpuls cpr uses an adjustable arm positioned over a compression pad, leaving much of the chest accessible to medical personnel; a supporting board and securing straps hold the system in place, with multiple styles of boards available for different clinical settings. Per the manufacturer, compression rates can be adjusted between 80 and 120 per minute, with depths from 2 to 6 cm; the device weighs 5.5 kg (approximately 12 lbs) with its battery and compression pad, and typically runs for about 90 minutes on a single charge; settings can be changed during operation, and the system automatically checks and adjusts the compression pad's position. The official product page adds: operating temperatures of -20°C to +45°C, compression data saved to an SD card, and Bluetooth/NFC data exchange with the corpuls 3 monitor. The design is intended for use in ambulances, hospitals and patient transport, including air rescue, where crew movement and access to the patient can be limited; it is already certified under European medical-device rules and can be used on patients as young as eight years old, in markets where that use is authorized. Here too, U.S. availability awaits FDA authorization.

4. Three Takeaways

1) The "lightweighting" of monitoring equipment is shrinking the cables and bulk inside the cabin. From fingertip pulse oximeters to in-ear multi-parameter monitoring, the smaller the device, the more operating space for the crew and the more care space for the patient; on a long transport, one less constraint is itself part of care quality. 2) Mechanical CPR devices are becoming a candidate "standard configuration" in transport settings. In a confined cabin, a single-arm design lets the device and hands-on care work in parallel; it must be emphasized, however, that whether a device is appropriate and how compression parameters are set are clinical decisions made by the medical team based on the patient's condition — the coordinator's role is to align resources that hold the corresponding conditions and authorizations. 3) Regulatory status is a frequently overlooked planning variable in cross-border medical transport. "Where a device is approved" and "where it can be used" are not the same thing: approved in Europe does not mean available in the U.S., and does not automatically mean available in China either. In cross-border transport coordination, the device's authorization scope deserves to sit on the same checklist as clinical assessment and route permits.

On the surface, progress in air medical transport looks like new models and new technology; at its core, it has always been the same thing: within limited space, limited time and uncontrollable environments, getting every detail that benefits the patient right. When a German company puts an 8.6-gram monitor in the ear canal and hands sustained compressions to a battery, the industry sees equipment advancing; what coordination and dispatch services must do is make sure these advances reach patients in every specific mission — compliantly, and in the right configuration.

Disclaimer: The facts in this article are drawn from the Vertical Mag report "Smaller sensors, smarter CPR: corpuls brings new air medical tech to AMTC 2026" (published October 29, 2026; accessed and verified October 30, 2026) and from corpuls' official product pages (corpuls.com/en/products/corpuls-auryx/ and corpuls.com/en/products/corpuls-cpr/, accessed and verified October 30, 2026). All facts attributed above — corpuls' founding in 1982, its base in Kaufering, Germany, its operations in more than 75 countries, its introduction of two products at AMTC 2026 in Fort Worth, Texas, the statements by Dr. Eva Meyer and Chris Karageorge, the auryx's 8.6-gram weight and measurement of SpO2, pulse rate and body temperature with Bluetooth transmission, pulse waveform tracking, the three-axis accelerometer, more than 10 hours of battery life, the two-pack with three ear-tip sizes, European Class IIb certification, its August 2026 international market entry, the corpuls cpr's single-arm layout, compression rates of 80–120 per minute, depths of 2–6 cm, weight of 5.5 kg with battery and pad, approximately 90 minutes of runtime per charge, adjustable settings during operation with automatic pad-position checking, intended applications including air rescue in confined spaces, European certification, use on patients as young as eight years old where authorized, and the fact that both devices await U.S. FDA authorization with no announced launch date or pricing — are as recounted in those sources. Discussions of monitoring lightweighting and resuscitation standardization are general industry analysis and do not constitute legal, medical or operational-licensing advice; whether a device is appropriate for a specific patient and how compression parameters are set are clinical decisions to be made by qualified medical institutions and medical teams; civilian air medical transport must be executed by carrier organizations and medical institutions holding the appropriate qualifications. BOOZOUN is an aviation medical coordination and dispatch service provider, not a carrier or medical institution; flight medical teams are dispatched by partner medical institutions. In an emergency, call local emergency services immediately.